Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation

Clinical Cardiology

Volumn 24, Issue 3, 2001, Pages 238-244

  Frick, Mats ^a   Frykman, Viveka ^a   Jensen Urstad, Mats ^b   Östergren, Jan ^b  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Arrhythmias; Atrial fibrillation; Cardioversion

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DILTIAZEM; SOTALOL; VERAPAMIL; WARFARIN;

ADULT; AGED; ARTICLE; CARDIOVERSION; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART RATE; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; RECURRENT DISEASE; THROMBOEMBOLISM; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BODY WEIGHT; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; LOGISTIC MODELS; MALE; PROSPECTIVE STUDIES; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0035112291     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960240313     Document Type: Article

References (37)

1. Epidemiological features of chronic atrial fibrillation: The Framingham study
2. Atrial fibrillation: Epidemiology and the risk and prevention of stroke
3. Impact of atrial fibrillation on the risk of death: The Framingham study
4. Atrial fibrillation follow-up investigation of rhythm management - The AFFIRM study design
5. Electrical reversion of cardiac arrhythmias
6. An evaluation of DC shock treatment of atrial arrhythmias: Immediate results and complications in 473 patients with long term results in the first 290 of these
7. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation
8. Relation between echocardiographically determined left atrial size and atrial fibrillation
9. Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation
10. Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation
11. Success of serial cardioversion therapy and safety of oral anticoagulation
12. Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or flutter
13. Risk factors for the development of recurrent atrial fibrillation: Role of pacing and clinical variables
14. Efficacy of serial electrical cardioversion therapy in patients with chronic atrial fibrillation after valve replacement and implications to cure atrial fibrillation
15. Cardioversion of atrial fibrillation in elderly
16. Relation between left atrial dimension and duration of atrial fibrillation
17. Atrial fibrillation and atrial enlargement in patient with mitralis stenosis
18. Arythmie auriculaire d'origine vagale ou cathécholergique: Effects comparés du traitement béta-blouquant et phénomène d'échappement
19. Heart rate variability in patients with atrial fibrillation is related to vagal tonus
20. Low vagal tone and supraventricular ectopic activity predict atrial fibrillation and flutter after coronary artery bypass graft
21. Longest RR interval in atrial fibrillation predicts outcome of subsequent cardioversion: A prospective study
22. Standardized intracardiac measurements of two-dimensional echocardiography
23. Echocardiographic measurements in normal subjects from infancy to old age
24. Beat-to-beat left ventricular performance in atrial fibrillation: Radionuclide assessment with the computerized nuclear probe
25. Comparison of different echocardiographic methods with radionuclide imaging for measuring left ventricular ejection fraction during acute myocardial infarction treated by thrombolytic therapy
26. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography
27. Transthoracic resistance in human defibrillation. Influence of body weight, chest size, serial shocks, paddle size and paddle contact pressure
28. Low energy transvenous cardioversion of atrial fibrillation resistant to transthoracic shocks
29. Management of patients with atrial fibrillation. A state care for healthcare professionals. From the Subcommittee on Electrocardiography and Electrophysiology. American Heart Association
30. Atrial fibrillation: Maintenance of sinus rhythm versus rate control
31. Efficacy and safety of quinidine therapy for the maintenance of sinus rhythm after cardioversion
32. Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation
33. Verapamil reduces tachycardia-induced electrical remodeling of the atria
34. Early recurrences of atrial fibrillation after electrical cardioversion: A result of fibrillation-induced electrical remodelling of the atria?
35. Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion
36. Prevention of supraventricular arrhythmias after coronary artery bypass grafting. A meta-analysis of randomized control trials
37. Echocardiographic left atrial dimension as a predictor of maintaining sinus rhythm after cardioversion of atrial fibrillation